nucleoside derivatives (Zhengzhou University/Beijing Institute of Radiation Medicine/Collaborative Innovation Center of New Drug Research and Safety Evaluation)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namenucleoside derivatives (Zhengzhou University/Beijing Institute of Radiation Medicine/Collaborative Innovation Center of New Drug Research and Safety Evaluation)
Drug Alias Namealpha-DDB-FNCGalpha-DDB-DU
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhengzhou University
China Registration ClassN/A

Other Information

ATC CodeN/A
Related LinksN/A